Press Releases

Dr. William A. Vega, executive director of the USC Edward R. Roybal Institute on Aging at the USC Suzanne Dworak-Peck School of Social Work, was officially announced as a new member of the UsAgainstAlzheimer’s (UsA2) Network Board of Directors, where he will apply his deep knowledge in the areas of population health, gerontology and minority health to advance the organization’s mission to cure Alzheimer’s, the third-leading cause of death In the United States.

A bipartisan agreement to increase Alzheimer’s funding by $400 million at the National Institutes of Health (NIH) for FY 2017, part of a total spending increase of $2 billion at NIH, is a major achievement.  Congressional leaders, bolstered by thousands of advocates, including patients, caregivers, family members and allies, have responded to the urgent need to find a cure for Alzheimer’s, which affects more than 5.5 million Americans. 

Important new survey findings released today by WomenAgainstAlzheimer’s and the National Association of Nurse Practitioners in Women’s Health (NPWH) show that approximately 30 percent of nurse practitioners (NPs) in women’s health do not raise brain health issues with patients, while only 18 percent of nurse practitioners occasionally broach the issues during office visits. In fact, 68 percent of the time, patients are raising brain health issues, rather than the nurse practitioners treating them. 

UsAgainstAlzheimer’s Co-Founder and Vice Chair Trish Vradenburg’s unflinching spirit – her creativity and imagination, quick-witted humor, empathy, generosity and her exceptional tenacity to stop the suffering of others – was captured in her every action. It is with immense sadness that UsAgainstAlzheimer’s announces her passing, and it is with the utmost gratitude that the organization cherishes her legacy and forges ahead in her memory.

Doubling down on the deep cuts to the National Institutes of Health (NIH) in its proposed FY 2018 budget, the Administration’s proposed NIH budget cuts for FY 2017, a reduction of $1.2 billion from current levels, represent an assault on the hopes of millions with Alzheimer’s and related dementias who are desperate for a cure.


^ Back to Top